Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
Hye Kyung HyunHye-Won LeeJihye ParkSoo Jung ParkJae Jun ParkTae Il KimJae Seung LeeBeom Kyung KimJun Yong ParkDo-Young KimSang Hoon AhnSeung-Up KimJae Hee CheonPublished in: Gut and liver (2023)
Hepatic steatosis was independently associated with increased risks of clinical relapse in patients with ulcerative colitis and Crohn's disease, whereas fibrotic burden in the liver was not. Future studies should investigate whether assessment and therapeutic intervention for NAFLD will improve the clinical outcomes of patients with IBD.